Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study. Jindal, T., Kilari, D., Alhalabi, O., Nizam, A., Khaki, A., Basu, A., Barata, P. C., Bilen, M., Shah, S., Zakharia, Y., Milowsky, M. I., Bellmunt, J., Emamekhoo, H., Davis, N. B., Grivas, P., Gupta, S., Hoimes, C. J., Campbell, M. T., Alva, A., Koshkin, V. S. LIPPINCOTT WILLIAMS & WILKINS. 2023

View details for Web of Science ID 001098050200479